IDORSIA

Headquartered in Switzerland - a biotech-hub of Europe - Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options... The purpose of Idorsia is to discover, develop and bring more, innovative medicines to patients.

Also known as: Idorsia (Beijing) Pharmaceuticals Co., Ltd, Idorsia (Shanghai) Pharmaceuticals Co., Ltd, Idorsia Clinical Development US Inc., Idorsia Pharmaceuticals, Idorsia Pharmaceuticals Canada Ltd., Idorsia Pharmaceuticals Deutschland GmbH, Idorsia Pharmaceuticals Germany GmbH, Idorsia Pharmaceuticals Ltd, Idorsia Pharmaceuticals US Inc., Idorsia US Holding Company Inc.

Primary location: Allschwil Switzerland